SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Anchoring the new blueprint for the 15th Five-Year Plan, Harbin Bank uses its financial strength to assist in the high-quality development of the Heilongjiang economy.
CHINA CHUNLAI (01969): Reduce leverage, increase cash, support "strategic investment" long-termism with financial prudence.
HK Bull/Bear Outstanding Qty Ratio(60:40) | November 29th
Anchoring the new blueprint for the 15th Five-Year Plan, Harbin Bank uses its financial strength to assist in the high-quality development of the Heilongjiang economy.
CHINA CHUNLAI (01969): Reduce leverage, increase cash, support "strategic investment" long-termism with financial prudence.
HK Bull/Bear Outstanding Qty Ratio(60:40) | November 29th
RECOMMEND
Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025
Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025
Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025
